Inflammatory cytokines as predictive markers for early detection and progression of diabetic nephropathy

38Citations
Citations of this article
52Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Diabetic nephropathy is a major complication of diabetes mellitus and the leading cause of end-stage renal disease. Both hyperglycemia and hypertension (systemic and/or intraglomerular) are established causal factors for diabetic nephropathy. Nonetheless, there is growing evidence that activated innate immunity and inflammation are also contributing factors to the pathogenesis of diabetic nephropathy. This notion is based on increasing evidence indicating that both cytokines-chemokines and pro-fibrotic growth factors are important players in the progression of diabetic nephropathy, effectively accelerating and exacerbating inflammatory and fibrotic processes leading to endstage renal disease. In this review, we focus on several predominant cytokines-chemokines as potential predictive markers for diabetic nephropathy. These cytokineschemokines may also be helpful as biomarkers to monitor the progression of the disease and the impact of interventional modalities aimed at halting eventual manifestation of end-stage renal disease in diabetic patients. © European Association for Predictive, Preventive and Personalised Medicine 2010.

Cite

CITATION STYLE

APA

Elmarakby, A. A., Abdelsayed, R., Liu, J. Y., & Mozaffari, M. S. (2010, March). Inflammatory cytokines as predictive markers for early detection and progression of diabetic nephropathy. EPMA Journal. https://doi.org/10.1007/s13167-010-0004-7

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free